Cargando…
Salient networks: a novel application to study Alzheimer disease
BACKGROUND: Extracting fundamental information from data, thus underlining hidden structures or removing noisy information, is one of the most important aims in different scientific fields especially in biological and medical sciences. In this article, we propose an innovative complex network applic...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245497/ https://www.ncbi.nlm.nih.gov/pubmed/30458801 http://dx.doi.org/10.1186/s12938-018-0566-5 |
_version_ | 1783372254426431488 |
---|---|
author | Amoroso, Nicola Diacono, Domenico La Rocca, Marianna Bellotti, Roberto Tangaro, Sabina |
author_facet | Amoroso, Nicola Diacono, Domenico La Rocca, Marianna Bellotti, Roberto Tangaro, Sabina |
author_sort | Amoroso, Nicola |
collection | PubMed |
description | BACKGROUND: Extracting fundamental information from data, thus underlining hidden structures or removing noisy information, is one of the most important aims in different scientific fields especially in biological and medical sciences. In this article, we propose an innovative complex network application able to identify salient links for detecting the effect of Alzheimer’s disease on brain connectivity. We first build a network model of brain connectivity from structural Magnetic Resonance Imaging (MRI) data, then we study salient networks retrieved from the original ones. RESULTS: Investigating informative power of the salient skeleton features in combination with those of the original networks we obtain an accuracy of [Formula: see text] for the distinction of Alzheimer disease (AD) patients from normal controls (NC). This performance significantly overcomes accuracy of the original network features. Moreover salient networks are able to correctly discriminate normal controls (NC) from AD patients and NC from subjects with mild cognitive impairment that will convert to AD (cMCI). These evaluations, performed on an independent dataset, give an accuracy of [Formula: see text] and [Formula: see text] respectively for NC-AD and NC-cMCI classifications. Therefore, most of the informative content of the original networks is kept after the 92 [Formula: see text] and 82 [Formula: see text] reduction respectively in the number of nodes and links. In addition, the present approach, applied to a publicly available MRI dataset from the Alzheimer Disease Neuroimaging Initiative (ADNI), brings out also some interesting aspects related to the topologies and hubs of the networks. CONCLUSIONS: The experimental results demonstrate how salient networks can highlight important brain network characteristics and structural pathological changes, while reducing considerably data complexity and computational requirements. |
format | Online Article Text |
id | pubmed-6245497 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62454972018-11-26 Salient networks: a novel application to study Alzheimer disease Amoroso, Nicola Diacono, Domenico La Rocca, Marianna Bellotti, Roberto Tangaro, Sabina Biomed Eng Online Research BACKGROUND: Extracting fundamental information from data, thus underlining hidden structures or removing noisy information, is one of the most important aims in different scientific fields especially in biological and medical sciences. In this article, we propose an innovative complex network application able to identify salient links for detecting the effect of Alzheimer’s disease on brain connectivity. We first build a network model of brain connectivity from structural Magnetic Resonance Imaging (MRI) data, then we study salient networks retrieved from the original ones. RESULTS: Investigating informative power of the salient skeleton features in combination with those of the original networks we obtain an accuracy of [Formula: see text] for the distinction of Alzheimer disease (AD) patients from normal controls (NC). This performance significantly overcomes accuracy of the original network features. Moreover salient networks are able to correctly discriminate normal controls (NC) from AD patients and NC from subjects with mild cognitive impairment that will convert to AD (cMCI). These evaluations, performed on an independent dataset, give an accuracy of [Formula: see text] and [Formula: see text] respectively for NC-AD and NC-cMCI classifications. Therefore, most of the informative content of the original networks is kept after the 92 [Formula: see text] and 82 [Formula: see text] reduction respectively in the number of nodes and links. In addition, the present approach, applied to a publicly available MRI dataset from the Alzheimer Disease Neuroimaging Initiative (ADNI), brings out also some interesting aspects related to the topologies and hubs of the networks. CONCLUSIONS: The experimental results demonstrate how salient networks can highlight important brain network characteristics and structural pathological changes, while reducing considerably data complexity and computational requirements. BioMed Central 2018-11-20 /pmc/articles/PMC6245497/ /pubmed/30458801 http://dx.doi.org/10.1186/s12938-018-0566-5 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Amoroso, Nicola Diacono, Domenico La Rocca, Marianna Bellotti, Roberto Tangaro, Sabina Salient networks: a novel application to study Alzheimer disease |
title | Salient networks: a novel application to study Alzheimer disease |
title_full | Salient networks: a novel application to study Alzheimer disease |
title_fullStr | Salient networks: a novel application to study Alzheimer disease |
title_full_unstemmed | Salient networks: a novel application to study Alzheimer disease |
title_short | Salient networks: a novel application to study Alzheimer disease |
title_sort | salient networks: a novel application to study alzheimer disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245497/ https://www.ncbi.nlm.nih.gov/pubmed/30458801 http://dx.doi.org/10.1186/s12938-018-0566-5 |
work_keys_str_mv | AT amorosonicola salientnetworksanovelapplicationtostudyalzheimerdisease AT diaconodomenico salientnetworksanovelapplicationtostudyalzheimerdisease AT laroccamarianna salientnetworksanovelapplicationtostudyalzheimerdisease AT bellottiroberto salientnetworksanovelapplicationtostudyalzheimerdisease AT tangarosabina salientnetworksanovelapplicationtostudyalzheimerdisease AT salientnetworksanovelapplicationtostudyalzheimerdisease |